Harvard Bioscience, Inc. Stock price
Equities
HBIO
US4169061052
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.2 USD | +4.48% | -4.55% | -21.50% |
Mar. 07 | Transcript : Harvard Bioscience, Inc., Q4 2023 Earnings Call, Mar 07, 2024 | |
Mar. 07 | Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q4 Revenue $28.2M | MT |
Financials (USD)
Sales 2024 * | 114M | Sales 2025 * | 126M | Capitalization | 182M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 3M | EV / Sales 2024 * | 1.6 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.45 x |
P/E ratio 2024 * |
-840
x | P/E ratio 2025 * |
56
x | Employees | 404 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.29% |
Latest transcript on Harvard Bioscience, Inc.
1 day | +4.48% | ||
1 week | -4.55% | ||
Current month | -3.00% | ||
1 month | -4.98% | ||
3 months | -23.50% | ||
6 months | -0.24% | ||
Current year | -21.50% |
Managers | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Jennifer Cote
DFI | Director of Finance/CFO | 52 | 22-04-30 |
David Balcom
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Alan Edrick
BRD | Director/Board Member | 56 | 19-09-02 |
Bertrand Loy
BRD | Director/Board Member | 58 | 14-11-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.37% | 4 M€ | -5.15% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 36 M€ | +4.74% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 4.2 | +4.48% | 81,812 |
24-03-26 | 4.02 | -2.66% | 87,104 |
24-03-25 | 4.13 | -0.96% | 38,562 |
24-03-22 | 4.17 | -4.36% | 93,246 |
24-03-21 | 4.36 | -0.91% | 53,829 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.50% | 182M | |
+9.15% | 221B | |
+18.60% | 142B | |
+18.70% | 101B | |
+7.64% | 68.07B | |
+24.79% | 57.27B | |
-2.49% | 47.42B | |
+6.00% | 43.19B | |
+16.80% | 41.12B | |
+14.13% | 28.84B |